![Danilo Verge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Danilo Verge is currently the Chief Operating & Medical Officer at Viewmind, Inc. He previously worked as the Head-Global Medical Affairs at Zealand Pharma A from 2020 to 2022.
Dr. Verge holds an MBA from Copenhagen Business School, an undergraduate degree from St. Lawrence University, and a doctorate from Universidad de Buenos Aires.
| Companies | Position | Start |
|---|---|---|
Viewmind, Inc.
 Viewmind, Inc. Information Technology ServicesTechnology Services Operates as a digital health and artificial intelligence company that provides clinically validated solutions for precision assessment of neurocognitive disorders | Chief Operating Officer | 2023-08-21 |
| Companies | Position | End |
|---|---|---|
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | 2022-05-31 |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viewmind, Inc.
Viewmind, Inc. Information Technology ServicesTechnology Services Operates as a digital health and artificial intelligence company that provides clinically validated solutions for precision assessment of neurocognitive disorders | Technology Services |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
